HEAL ETF — Global X HealthTech ETF

Global X HealthTech ETF (HEAL)

Updated October 16, 2026.

HEAL is an ETF. its distribution rate is 0.25%, its trailing-12-month yield is 0.24%, its expense ratio is 0.50%. Dividend Vision Distribution Safety Score™ is 50/100 (Unproven). Total return is -36.3% over the past 6.2 years, 192.8 points behind SPY at 156.5%.

Global X HealthTech ETF tracks an index of exchange-listed companies positioned to benefit from advances in healthcare technology, investing at least 80% of assets in securities from its underlying index. The fund has a low distribution rate and does not maintain a regular distribution schedule; its most recent payout was special and may not recur. With an expense ratio of 0.50%, this ETF may appeal to investors seeking growth-oriented exposure to the healthtech sector rather than current income.

HEAL performance versus SPY

Price and return data through 2026-10-16.

Total return is -36.3% over the past 6.2 years, 192.8 points behind SPY at 156.5%. Over the past year its total return — price change plus distributions reinvested — is -8.4%. Its deepest 1-year drawdown was 30.1%.

HEAL key facts

Distribution Safety Score™

50 · Unproven

Issuer

Global X

Asset type

ETF

Asset class

Equity

Inception date

07/29/2020

Expense ratio

0.50%

Distribution rate

0.25%

Trailing yield

0.24%

Last close

$29.65 (as of 2026-10-16)

AUM

$31,155,437

Average volume

2997.0

Dividend

$0.07184

Ex-dividend date

12/30/2025

Payment date

01/07/2026

Beta

1.36

How Dividend Vision calculates yield and returns

Distribution rate (0.25%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (0.24%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: Global X or company page; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

HEAL risks and drawbacks

HEAL's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 30.1%.

Who may consider HEAL — and who may not

It is a weaker fit for investors hunting double-digit covered-call yields; investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on HEAL

• All tickers starting with H

Frequently asked questions

More securities from Global X.